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Previewsemployed a ubiquitous promoter to drive
expression of the Cyclin B1-GFP fusion
protein. Thus, the application of sorting
of live, proliferating cells can now be
expanded to the rare replicating neuron,
just as it can be to the rapidly regenerating
intestinal epithelium. Future work could
also make use of intercrossing of the
current transgenic line with other trans-
genic mice expressing fluorescent pro-
teins with different excitation/emission
properties in cells of interest, thus allow-ing for dual-label sorting of replicating
cells from complex tissues. The novel
tool developed by Klochendler and
colleagues thus represents in a major
step forward in the analysis of prolifera-
tion of normal mammalian cells and
tissues.REFERENCES
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Hedgehog signaling is transduced at the primary cilium, but the precise mechanisms underlying this action
are not clear. In this issue ofDevelopmental Cell, Dorn and colleagues (2012) describe a novel mechanism for
control of Hedgehog signaling by Evc proteins within the primary cilium.The Hedgehog (Hh) signaling pathway
has received enormous attention over
the years because it plays an essential
role in many aspects of vertebrate embry-
onic development and tumorigenesis (re-
viewed in Ingham et al., 2011). Despite
this focus, the biochemical steps leading
from ligand binding to target gene
activation are far from clear. Roughly
a decade ago, genetic experiments re-
vealed the requirement of the primary
cilium, a microtubule-based, membrane-
enclosed structure, for mammalian Hh
signaling. Subsequent work indicated
that this small yet nearly ubiquitous
‘‘organelle’’ represents a central process-
ing center where Hh signaling information
is transduced. Indeed, most of the
core factors regulating the pathway,
including a transmembrane activator lying
upstream in the pathway, Smoothened
(Smo), and the pathway effectors, the Gli
transcription factors, localize to primary
cilia in a manner gated by pathway
activity. Current models posit that acti-
vated Smo localizes to ciliary membranesin response to ligands, where it then
suppresses Protein Kinase A (PKA)-medi-
ated phosphorylation of the Gli proteins
and induces dissociation of Gli proteins
from their inhibitor, Suppressor of Fused
(SuFu). However, how each of these
events occurs at the biochemical level
within the cilium is unknown.
To begin to tackle this problem, Dorn
and colleagues (2012) have focused their
attention on the transmembrane protein
Evc2, which is mutated in two human
disorders, Ellis–van Creveld syndrome
(EvC) and Weyers acrodental dystosis
(Weyers) (Ruiz-Perez et al., 2000). EvC
and Weyers are classified as ‘‘ciliopa-
thies,’’ which encompass a spectrum of
related disorders caused by defective
ciliary structure or function. EvC is an
autosomal-recessive disorder in which
patients harbor loss-of-function muta-
tions in Evc2, the neighboring Evc2-inter-
acting protein Evc, or, in rare cases, both
proteins. Weyers is an autosomal-domi-
nant disorder with phenotypic character-
istics similar to EvC, and patients withthis disease harbor deletions in the C
terminus of Evc2. The fact that at least
some of the phenotypic features are
linked to dysregulation of the Hh pathway
led to previous studies showing that
mammalian Hh signaling requires Evc
proteins and that Evc and Evc2 localize
near the base of primary cilia (Blair et al.,
2011). Interestingly, the human and
mouse mutant phenotypes and evc
expression patterns suggest that this
requirement is tissue specific.
In the present work, Dorn et al. show
that Evc2, in a complex with Evc, physi-
cally associates with Smo in the cilium in
response to pathway activation. These
findings are backed up by similar results
from Jin Jiang and colleagues (Yang
et al., 2012). While Evc/Evc2 are required
for cilium-dependent Hh signaling, they
do not appear to control ciliary assembly
or structure. Epistasis analysis indicates
that these proteins act in the Hh pathway
at a step upstream of the Gli proteins and
the negative regulators SuFu and PKA.
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Previewsaffect the ability of Smo to localize to the
cilium upon ligand stimulation but does
interfere with steps downstream of Smo,
such as suppression of Gli proteolytic
processing, recruitment of Gli proteins
and SuFu to the tips of cilia, and Gli
nuclear localization. These and other
data raise the possibility that, through
their association with Smo, the Evc
proteins provide a link between active
ciliary Smo and downstream events of
the pathway. Both Evc2 and Evc localize
to a novel membrane subdomain within
the cilium lying just distal to the ciliary
transition zone, which the authors name
the ‘‘EvC zone.’’ These findings suggest
that the EvC zone is the critical location
in which Smo acts to control the Hh
pathway in the cilium. Restricting Evc2
to the EvC zone requires the so-called W
peptide, deleted in mutant Evc2 variants
of Weyers patients. Consistent with the
genetics, expression of Evc2 lacking this
peptide (Evc2DW) leads to its mislocaliza-
tion throughout the cilium and dominant
suppression of Hh signaling. Evc2DW
may inhibit the pathway by binding Smo
without the ability of endogenous Evc2
to homomultimerize. Interestingly, the W
peptide appears to be sufficient to restrict
localization of a heterologous protein,
Smo, to the EvC zone. In support of the
hypothesis that the EvC zone is the site
of Smo action, enriching Smo within this678 Developmental Cell 23, October 16, 2012zone increases its activity in response to
pathway stimulation.
The work raises a number of new ques-
tions and ideas. The most important of
these is the precise nature of Evc2 bio-
chemical function. While the data provide
a good argument for the importance of the
Evc2-Smo interaction in mediating Hh
signaling, they are consistent with either
of two modes of regulation: Evc2 may
transduce information from active Smo
to factors controlling Gli function, or
Evc2 may allow Smo to adopt a fully
active state once it has localized to the
cilium. Importantly, Evc2 does not appear
to directly interact with Gli proteins, PKA,
or SuFu, so if the first mode applies, the
nature of Gli regulation is likely to be indi-
rect and may require the identification of
additional Evc2-interacting proteins that
control Hh signaling. Because previous
work has extensively characterized the
changes in Smo conformation in re-
sponse to Hh signaling (Zhao et al.,
2007), this type of analysis may be used
to determine whether Evc proteins are
essential for a late step in the pathway
leading to formation of active ciliary
Smo. Another interesting result from this
study is the suggestion that although
Smo, Sufu, and Gli proteins primarily co-
localize at the tip of the cilium, active
Smo may only be functional in the EvC
zone. If this idea is correct, Gli proteinsª2012 Elsevier Inc.may be subject to Smo regulation during
their transport from the base to the tips
of cilia. Another important question that
remains is how the Hh pathway is regu-
lated in tissues such as the nervous
system, where Evc and Evc2 appear to
be dispensable. This point raises the
intriguing possibility that there is no
single, canonical Hh pathway acting in
mammals but, rather, that cells make
use of both core and tissue-specific
machinery to transduce Hh signaling
information depending on context.REFERENCES
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Paramutation, a phenomenon of epigenetic switching that violates Mendel’s Law of Segregation, was first
discovered in maize and later observed in other plants. In a recent report in Nature, de Vanssay and
colleagues (2012) describe in Drosophila an operationally analogous phenomenon to paramutation that is
mediated by piwi-interacting RNAs.Paramutation is an epigenetic switch that
violates Mendel’s Law of Segregation. In
this phenomenon, one allele changes the
activity state (usually to a silent state) of
its partner allele on the homologous chro-mosome. This new state of allelic activity
is inherited by the next generation and
beyond (Brink, 1956; Coe, 1959). The
newly modified allele also has the ability
in turn to change naive alleles. Paramuta-tion was first found in maize, and because
of its bizarre behavior it has captured and
retained the imagination of talented inves-
tigators for decades. Although there is
much to be learned of the mechanism,
